109 related articles for article (PubMed ID: 29274588)
1. α-asarone reduce proteinuria by restoring antioxidant enzymes activities and regulating necrosis factor κB signaling pathway in doxorubicin-induced nephrotic syndrome.
Sutariya B; Saraf M
Biomed Pharmacother; 2018 Feb; 98():318-324. PubMed ID: 29274588
[TBL] [Abstract][Full Text] [Related]
2. Curcumin, as a pleiotropic agent, improves doxorubicin-induced nephrotic syndrome in rats.
Fan HY; Wang XK; Li X; Ji K; Du SH; Liu Y; Kong LL; Xu JC; Yang GQ; Chen DQ; Qi D
J Ethnopharmacol; 2020 Mar; 250():112502. PubMed ID: 31881321
[TBL] [Abstract][Full Text] [Related]
3. Effects of Shenkangling intervention on the MAPK pathway in rats with doxorubicin-induced nephropathy.
Ai S; Lin YY; Zheng J; Qiu CX; Liu YJ; Lin X
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706571
[TBL] [Abstract][Full Text] [Related]
4. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
[TBL] [Abstract][Full Text] [Related]
5. NAC attenuates adriamycin-induced nephrotic syndrome in rats through regulating TLR4 signaling pathway.
Yao H; Cai ZY; Sheng ZX
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1938-1943. PubMed ID: 28485782
[TBL] [Abstract][Full Text] [Related]
6. Kidney dysfunction and oxidative stress in doxorubicin-induced nephrotic rat: Protective role of sesame oil.
Mahzari S; Hosseinian S; Hadjzadeh MA; Mohebbati R; Noshahr ZS; Rad AK
Saudi J Kidney Dis Transpl; 2021; 32(5):1243-1252. PubMed ID: 35532693
[TBL] [Abstract][Full Text] [Related]
7. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
[TBL] [Abstract][Full Text] [Related]
8. Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model.
Sonmez A; Yilmaz MI; Korkmaz A; Topal T; Caglar K; Kaya A; Eyileten T; Yenicesu M; Oguz Y; Basal S; Ipcioglu OM; Vural A
Clin Exp Nephrol; 2008 Apr; 12(2):110-118. PubMed ID: 18175058
[TBL] [Abstract][Full Text] [Related]
9. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
10. Huaiqihuang Granules () reduce proteinuria by enhancing nephrin expression and regulating necrosis factor κB signaling pathway in adriamycin-induced nephropathy.
Liu H; Sun W; Gu LB; Tu Y; Yu BY; Hu H
Chin J Integr Med; 2017 Apr; 23(4):279-287. PubMed ID: 26453563
[TBL] [Abstract][Full Text] [Related]
11. Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats.
Bou Matar RN; Klein JD; Sands JM
PLoS One; 2013; 8(1):e54738. PubMed ID: 23349960
[TBL] [Abstract][Full Text] [Related]
12. D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFκB in kidneys of Wistar rats.
Rehman MU; Tahir M; Khan AQ; Khan R; Oday-O-Hamiza ; Lateef A; Hassan SK; Rashid S; Ali N; Zeeshan M; Sultana S
Exp Biol Med (Maywood); 2014 Apr; 239(4):465-76. PubMed ID: 24586096
[TBL] [Abstract][Full Text] [Related]
13. Hyperbaric oxygen treatment augments the efficacy of a losartan regime in an experimental nephrotic syndrome model.
Yilmaz MI; Korkmaz A; Kaya A; Sonmez A; Caglar K; Topal T; Eyileten T; Yenicesu M; Acikel C; Oter S; Yaman H; Aktug H; Oguz Y; Vural A; Ikizler TA
Nephron Exp Nephrol; 2006; 104(1):e15-22. PubMed ID: 16699289
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis.
Zhang J; Cui L; Han X; Zhang Y; Zhang X; Chu X; Zhang F; Zhang Y; Chu L
Biomed Pharmacother; 2017 Sep; 93():1253-1260. PubMed ID: 28738542
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome.
Bulucu F; Oktenli C; Kenar L; Ocal R; Koc B; Inal V; Yamanel L; Yaman H; Sanisoglu YS; Aydin A
J Nephrol; 2008; 21(4):576-83. PubMed ID: 18651549
[TBL] [Abstract][Full Text] [Related]
16. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats.
Badary OA; Abdel-Naim AB; Abdel-Wahab MH; Hamada FM
Toxicology; 2000 Mar; 143(3):219-26. PubMed ID: 10755708
[TBL] [Abstract][Full Text] [Related]
17. Synergistic action of inflammation and lipid dysmetabolism on kidney damage in rats.
Wang Z; Huang W; Li H; Tang L; Sun H; Liu Q; Zhang L
Ren Fail; 2018 Nov; 40(1):175-182. PubMed ID: 29569980
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental nephrotic syndrome with artesunate.
Razavi A; Nouri HR; Mehrabian F; Mirshafiey A
Int J Toxicol; 2007; 26(4):373-80. PubMed ID: 17661229
[TBL] [Abstract][Full Text] [Related]
19. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells.
Guo RM; Xu WM; Lin JC; Mo LQ; Hua XX; Chen PX; Wu K; Zheng DD; Feng JQ
Mol Med Rep; 2013 Aug; 8(2):603-8. PubMed ID: 23807148
[TBL] [Abstract][Full Text] [Related]
20. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity.
El-Moselhy MA; El-Sheikh AA
Biomed Pharmacother; 2014 Feb; 68(1):101-10. PubMed ID: 24268999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
